The number of bioequivalence study protocol approved in the first half year (January-June) was a total of 85 cases
On June 30, according to the Ministry of Food and Drug Safety, the number of bioequivalence study protocol approved in the first half year (January-June) was a total of 85 cases.
Celebrex (Pfizer Korea, celecoxib) recorded the highest number of approved bioequivalence study protocol of 10 cases....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
